UK, drugmakers at odds over drug pricing plansnews2025-08-22T17:20:17+00:00August 22nd, 2025|Endpoints News|
Biohaven won’t face FDA advisory committee meeting for its SCA drugnews2025-08-22T15:43:44+00:00August 22nd, 2025|Endpoints News|
Obesity drug market hits turning point after lackluster results and lull in startupsnews2025-08-22T15:28:35+00:00August 22nd, 2025|Endpoints News|
OpenAI, Retro Bio detail results of AI model for proteinsnews2025-08-22T15:00:08+00:00August 22nd, 2025|Endpoints News|
Hong Kong’s IPO market is still active; Lighthouse’s $49M grant from NIHnews2025-08-22T14:47:15+00:00August 22nd, 2025|Endpoints News|
Lilly neuro exec Anne White to retire; Bristol Myers fills new medical affairs positionnews2025-08-22T11:00:32+00:00August 22nd, 2025|Endpoints News|
Arena BioWorks, which aims to reinvent biotech’s research model, lays off more staffnews2025-08-21T23:37:45+00:00August 21st, 2025|Endpoints News|
CDC staff won’t serve as members of ACIP’s new Covid-19 working groupnews2025-08-21T19:49:54+00:00August 21st, 2025|Endpoints News|
AbbVie’s Rinvoq clears second Phase 3 trial in hair loss diseasenews2025-08-21T18:31:28+00:00August 21st, 2025|Endpoints News|
Making sense of personal health recordsnews2025-08-21T17:06:01+00:00August 21st, 2025|Endpoints News|
